PROPOFOL INJECTION EMULSION

देश: कनाडा

भाषा: अंग्रेज़ी

स्रोत: Health Canada

इसे खरीदें

सक्रिय संघटक:

PROPOFOL

थमां उपलब्ध:

MARCAN PHARMACEUTICALS INC

ए.टी.सी कोड:

N01AX10

INN (इंटरनेशनल नाम):

PROPOFOL

डोज़:

10MG

फार्मास्यूटिकल फॉर्म:

EMULSION

रचना:

PROPOFOL 10MG

प्रशासन का मार्ग:

INTRAVENOUS

पैकेज में यूनिट:

15G/50G

प्रिस्क्रिप्शन प्रकार:

Prescription

उत्पाद समीक्षा:

Active ingredient group (AIG) number: 0121833001; AHFS:

प्राधिकरण का दर्जा:

APPROVED

प्राधिकरण की तारीख:

2022-03-21

उत्पाद विशेषताएं

                                _ _
_Page 1 of 38 _
PRODUCT MONOGRAPH
INCLUDING PATIENT MEDICATION INFORMATION
PR
PROPOFOL INJECTION
Propofol Injectable Emulsion, USP
Emulsion, 10 mg / mL (1% w / v), Intravenous
USP
General Anaesthetic
ATC CODE: N01AX10
Marcan Pharmaceuticals Inc.
2 Gurdwara Road, Suite#112,
Ottawa, ON, K2E1A2
Date of Initial
Authorization:
MAR 08, 2022
Submission Control No: 255332
_Page 2 of 38_
RECENT MAJOR LABEL CHANGES
Not Applicable
TABLE OF CONTENTS
SECTIONS OR SUBSECTIONS THAT ARE NOT APPLICABLE AT THE TIME OF
AUTHORIZATION ARE NOT LISTED.
1 INDICATIONS
.........................................................................................................................
4
1.1
P
EDIA TRICS
........................................................................................................................
4
1.2
G
ERIATRICS
........................................................................................................................
4
2 CONTRAINDICATIONS
..........................................................................................................
4
4 DOSAGE AND
ADMINISTRATION..........................................................................................
5
4.1
D
OSING CONSIDERA TIONS
..................................................................................................
5
4.2
R
ECOMMENDED
D
OSE AND
D
OSAGE
A
DJUSTMENT
............................................................... 6
INDUCTION OF GENERAL ANAESTHESIA
..............................................................................
6
4.3
R
ECONSTITUTION
............................................................................................................
12
4.4
A
DMINISTRA TION
............................................................................................................
12
5 OVERDOSAGE
..................................................................................................................
13
6 DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING
................................. 14
7
                                
                                पूरा दस्तावेज़ पढ़ें
                                
                            

अन्य भाषाओं में दस्तावेज़

उत्पाद विशेषताएं उत्पाद विशेषताएं फ़्रेंच 08-03-2022

इस उत्पाद से संबंधित अलर्ट देखें

दस्तावेज़ इतिहास देखें